Brief: Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing
Today 23:18
BRIEF-Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing Oct 22 (Reuters) - Lucid Diagnostics Inc LUCD.O:
LUCID DIAGNOSTICS BEGINS RECEIVING MEDICARE REIMBURSEMENT FOR ESOGUARD® AND CLOSES $15 MILLION FINANCING
Source text: ID:nPn89tqVFa
Further company coverage: LUCD.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on PAVmed
See all newsBrief: Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing
PAVmed Inc reports results for the quarter ended June 30 - Earnings Summary
PAVmed Inc expected to post a loss of 47 cents a share - Earnings Preview
NASDAQ RESUMED AT 11:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:21 AM